New York Life Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
New York Life Investment Management's AMGN Position: Q2 2026 in Review
New York Life Investment Management increased its Amgen (AMGN) stake by 16% in Q2 2026, buying an estimated $4.06M and bringing the position to 86,677 shares worth $31.4M. The position accounts for 0.22% of the portfolio, ranked #90.
New York Life Investment Management first reported a position in AMGN in Q2 2022 and has held it in 17 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- New York Life Investment Management held 86,677 shares of Amgen worth $31.4M as of Q2 2026.
- New York Life Investment Management bought 11,854 Amgen shares in Q2 2026, an estimated $4.06M.
- Amgen made up 0.22% of New York Life Investment Management's portfolio in Q2 2026, its #90 holding.
- New York Life Investment Management first reported a position in Amgen in Q2 2022 and has held it in 17 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.